Warning! GuruFocus detected
1 Severe warning sign
with 190A.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Chordia Therapeutics Inc
ISIN : JP3283730004
Description
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.9 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -42.9 | |||||
| 3-Year EPS without NRI Growth Rate | -57 | |||||
| 3-Year FCF Growth Rate | -58.1 | |||||
| 3-Year Book Growth Rate | 25.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.67 | |||||
| 9-Day RSI | 51.67 | |||||
| 14-Day RSI | 49.78 | |||||
| 3-1 Month Momentum % | -13.8 | |||||
| 6-1 Month Momentum % | -5.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.78 | |||||
| Quick Ratio | 9.78 | |||||
| Cash Ratio | 9.19 | |||||
| Days Payable | 155.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.1 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -16.26 | |||||
| ROA % | -14.99 | |||||
| ROIC % | -520.65 | |||||
| 3-Year ROIIC % | 965.54 | |||||
| ROC (Joel Greenblatt) % | -4009.29 | |||||
| ROCE % | -15.53 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.12 | |||||
| Price-to-Tangible-Book | 4.12 | |||||
| EV-to-EBIT | -22.53 | |||||
| EV-to-EBITDA | -22.53 | |||||
| EV-to-FCF | -6.57 | |||||
| Price-to-Net-Current-Asset-Value | 4.14 | |||||
| Price-to-Net-Cash | 4.44 | |||||
| Earnings Yield (Greenblatt) % | -4.44 | |||||
| FCF Yield % | -11.23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chordia Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -16.89 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 49.78 | ||
| 14-Day ATR (円) | 14.12042 | ||
| 20-Day SMA (円) | 255.95 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (円) | 142 - 930 | ||
| Shares Outstanding (Mil) | 68.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chordia Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chordia Therapeutics Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chordia Therapeutics Inc Frequently Asked Questions
What is Chordia Therapeutics Inc(TSE:190A)'s stock price today?
The current price of TSE:190A is 円253.00. The 52 week high of TSE:190A is 円930.00 and 52 week low is 円142.00.
When is next earnings date of Chordia Therapeutics Inc(TSE:190A)?
The next earnings date of Chordia Therapeutics Inc(TSE:190A) is .
Does Chordia Therapeutics Inc(TSE:190A) pay dividends? If so, how much?
Chordia Therapeutics Inc(TSE:190A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers